...
首页> 外文期刊>Acta Neuropathologica >Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing
【24h】

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

机译:基于DNA焦磷酸测序的脑胶质瘤中IDH1和IDH2突变状态的快速灵敏评估

获取原文
获取原文并翻译 | 示例
           

摘要

Diffusely infiltrating cerebral gliomas frequently carry point mutations in codon 132 of the isocitrate dehydrogenase 1 (IDH1) gene or in codon 172 of the IDH2 gene, which are both clinically important as diagnostic and prognostic markers. Here, we report on a method that allows for the rapid detection of IDH1 and IDH2 mutations based on pyrosequencing. The method is applicable to routinely processed tissue specimens and provides quantitative mutation data within less than one working day. Due to its high sensitivity, the technique may also be used for the diagnostic assessment of IDH1 or IDH2 mutation in tissue samples with low tumor cell content, such as the infiltration zone of diffuse gliomas. Using pyrosequencing and/or conventional cycle sequencing of IDH1 and IDH2 in 262 gliomas, we confirm frequent mutations in diffuse astrocytic and oligodendroglial gliomas, corroborate a prognostic role for IDH1 mutation in primary glioblastomas and show that pleomorphic xanthoastrocytomas generally lack mutations in these genes.
机译:弥漫性浸润性脑胶质瘤经常在异柠檬酸脱氢酶1(IDH1)基因的132位密码子或IDH2基因的172位密码子中携带点突变,这在临床上均作为诊断和预后标志物非常重要。在这里,我们报告了一种基于焦磷酸测序可以快速检测IDH1和IDH2突变的方法。该方法适用于常规处理的组织标本,并在不到一个工作日内提供定量突变数据。由于其高灵敏度,该技术还可用于诊断肿瘤细胞含量低的组织样本(如弥漫性胶质瘤的浸润区)中IDH1或IDH2突变的诊断评估。使用焦磷酸测序和/或262个胶质瘤中IDH1和IDH2的常规循环测序,我们确认了弥漫性星形胶质细胞瘤和少突胶质神经胶质瘤中的频繁突变,证实了IDH1突变在原发性胶质母细胞瘤中的预后作用,并显示多形性黄体星形细胞瘤通常在这些基因中缺乏突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号